Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stan Gronthos

Showing results (141-150 of 172) with videos related to

Pageof 18
Sort By:
Molecules and Cells|May 27, 2011
Development of novel monoclonal antibodies that define differentiation stages of human stromal (mesenchymal) stem cellsDitte C Andersen, Angela Kortesidis, Andrew C W Zannettino, et al.
Stem Cells (Dayton, Ohio)|December 25, 2014
Brief report: the differential roles of mTORC1 and mTORC2 in mesenchymal stem cell differentiationSally K Martin, Stephen Fitter, Ankit K Dutta, et al.
Bone|January 31, 2004
The nitrogen-containing bisphosphonate, zoledronic acid, increases mineralisation of human bone-derived cells in vitroBeiqing Pan, Luen Bik To, Amanda N Farrugia, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|April 2, 2009
Targeted disruption of the CXCL12/CXCR4 axis inhibits osteolysis in a murine model of myeloma-associated bone lossPeter Diamond, Agatha Labrinidis, Sally K Martin, et al.
Placenta|March 20, 2016
Establishment and characterization of fetal and maternal mesenchymal stem/stromal cell lines from the human term placentaSharon Q Qin, Gina D Kusuma, Batla Al-Sowayan, et al.
Cancer Letters|February 5, 2020
Twist-1 is upregulated by NSD2 and contributes to tumour dissemination and an epithelial-mesenchymal transition-like gene expression signature in t(4;14)-positive multiple myelomaChee Man Cheong, Krzysztof M Mrozik, Duncan R Hewett, et al.
Cancer Research|March 9, 2005
Elevated serum levels of stromal-derived factor-1alpha are associated with increased osteoclast activity and osteolytic bone disease in multiple myeloma patientsAndrew C W Zannettino, Amanda N Farrugia, Angela Kortesidis, et al.
Cells|October 25, 2024
Multispectral Imaging of Collagen, NAD(P)H and Flavin Autofluorescence in Mesenchymal Stem Cells Undergoing Trilineage DifferentiationJared M Campbell, Saabah B Mahbub, Ayad G Anwer, et al.
Scientific Reports|September 30, 2018
mTORC1 plays an important role in osteoblastic regulation of B-lymphopoiesisSally K Martin, Stephen Fitter, Nadia El Khawanky, et al.
Plos One|July 10, 2008
Pharmacologic stem cell based intervention as a new approach to osteoporosis treatment in rodentsTakayoshi Yamaza, Yasuo Miura, Yanming Bi, et al.
Pageof 18

Showing results (141-150 of 172) with videos related to

Sort By:
Pageof 18
Molecules and Cells|May 27, 2011
Development of novel monoclonal antibodies that define differentiation stages of human stromal (mesenchymal) stem cellsDitte C Andersen, Angela Kortesidis, Andrew C W Zannettino, et al.
Stem Cells (Dayton, Ohio)|December 25, 2014
Brief report: the differential roles of mTORC1 and mTORC2 in mesenchymal stem cell differentiationSally K Martin, Stephen Fitter, Ankit K Dutta, et al.
Bone|January 31, 2004
The nitrogen-containing bisphosphonate, zoledronic acid, increases mineralisation of human bone-derived cells in vitroBeiqing Pan, Luen Bik To, Amanda N Farrugia, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|April 2, 2009
Targeted disruption of the CXCL12/CXCR4 axis inhibits osteolysis in a murine model of myeloma-associated bone lossPeter Diamond, Agatha Labrinidis, Sally K Martin, et al.
Placenta|March 20, 2016
Establishment and characterization of fetal and maternal mesenchymal stem/stromal cell lines from the human term placentaSharon Q Qin, Gina D Kusuma, Batla Al-Sowayan, et al.
Cancer Letters|February 5, 2020
Twist-1 is upregulated by NSD2 and contributes to tumour dissemination and an epithelial-mesenchymal transition-like gene expression signature in t(4;14)-positive multiple myelomaChee Man Cheong, Krzysztof M Mrozik, Duncan R Hewett, et al.
Cancer Research|March 9, 2005
Elevated serum levels of stromal-derived factor-1alpha are associated with increased osteoclast activity and osteolytic bone disease in multiple myeloma patientsAndrew C W Zannettino, Amanda N Farrugia, Angela Kortesidis, et al.
Cells|October 25, 2024
Multispectral Imaging of Collagen, NAD(P)H and Flavin Autofluorescence in Mesenchymal Stem Cells Undergoing Trilineage DifferentiationJared M Campbell, Saabah B Mahbub, Ayad G Anwer, et al.
Scientific Reports|September 30, 2018
mTORC1 plays an important role in osteoblastic regulation of B-lymphopoiesisSally K Martin, Stephen Fitter, Nadia El Khawanky, et al.
Plos One|July 10, 2008
Pharmacologic stem cell based intervention as a new approach to osteoporosis treatment in rodentsTakayoshi Yamaza, Yasuo Miura, Yanming Bi, et al.
Pageof 18